Medicines List

Description

Tirofiban-Tchaikapharma belongs to group of medicines called antithrombotic agents. Tirofiban prevents platelets from sticking together and thus forming blood clots, which can reduce blood flow to the heart and cause chest pain and heart attacks.

Indications

Tirofiban-Tchaikapharma is indicated for the prevention of adult patients with acute coronary syndromes without ST elevation (NSTE-ACS) with the last episode of chest pain occurring within 12 hours and with ECG changes and/or elevated cardiac enzymes. Patients who are most likely to benefit from Tirofiban-Tchaikapharma treatment are those at high risk of developing myocardial infarction within the first 3-4 days after onset of acute angina symptoms including for instance those who are likely to undergo an early percutaneous coronary intervention (PCI). Tirofiban-Tchaikapharma is also indicated for the reduction of major cardiovascular events in patients with acute myocardial infarction (STEMI) intended for primary PCI.

Tirofiban-Tchaikapharma is intended for use with acetylsalicylic acid (ASA) and unfractionated heparin.

Subject to medical prescription.

Concentration and pharmaceutical form: 0.25 mg/ml concentrate for solution for infusion

Description

Cardifriend-Co is a combination of two medicines – ramipril and hydrochlorothiazide.

Ramipril belongs to a group of medicines called “ACE inhibitors” (Angiotensin Converting Enzyme Inhibitors).
It works by:
– decreasing body production of substances that raise blood pressure;
– making blood vessels relax and widen;
– making it easier for your heart to pump blood around the body.

Hydrochlorothiazide belongs to a group of medicines called “thiazide diuretics” or water tablets. It works by increasing the amount of water (urine) the body produces. This lowers blood pressure.

Indications

Cardifriend-Co is indicated for treatment of hypertension. This fixed dose combination is indicated in patients whose blood pressure is not adequately controlled with ramipril alone or hydrochlorothiazide alone.

Subject to medical prescription.

Concentration and pharmaceutical form: 5 mg/12.5 mg tablets

Description

Bacteripime is a broad-spectrum cephalosporin antibiotic for intramuscular and intravenous administration.

Indications

Bacteripime is indicated in the treatment of infections caused by bacteria susceptible to cefepime, resistant to other antibiotics:

– lower respiratory tract infections, including pneumonia and bronchitis;
– uncomplicated and complicated urinary tract infections, including pyelonephritis;
– skin and subcutaneous tissue infection;
– intrabdominal infection, including peritonitis, and biliary tract infections;
– gynecological infections;
– treatment of patients with bacteremia that is related or suspected to be related to any of the infections listed above;
– empirical therapy for febrile neutropenia (reduction of neutrophil leukocytes in peripheral blood).

Subject to medical prescription.

Concentration and pharmaceutical form: 1 g powder for solution for injection/infusion

Description

The active ingredient in LanzAcid is lansoprazole. It belongs to a group of medicines called proton pump inhibitors.
LanzAcid works by lowering the amount of acid in your stomach.

Indications

LanzAcid is used for:
– Healing ulcers in your stomach or duodenum (gut);
– Healing and preventing ulcers caused by medicines called Non-Steroidal Anti-Inflammatory Drugs (NSAIDs). This includes medicines like aspirin, ibuprofen, ketoprofen and piroxicam;
– Gastro-Oesophageal Reflux Disease (GORD). This happens when acid from your stomach escapes into your food pipe (oesophagus) causing damage and inflammation;
Lansoprazole can relieve symptoms that can happen with the above conditions and stop them from coming back;
– The pain of indigestion or heartburn caused by too much acid (acid-related dyspepsia) in your stomach;
– Illnesses, such as Zollinger-Ellison Syndrome, where the stomach makes large amounts of acid. This can lead to diarrhoea and pain in the stomach;
– Infections caused by the bacteria Helicobacter pylori when lansoprazole is given in combination with antibiotic therapy.

Subject to medical prescription.

Concentration and pharmaceutical form: 30 mg gastro-resistant capsules, hard